123 related articles for article (PubMed ID: 26700144)
1. New surprises from an old favourite: The emergence of telomerase as a key player in the regulation of cancer stemness.
Teralı K; Yilmazer A
Biochimie; 2016 Feb; 121():170-8. PubMed ID: 26700144
[TBL] [Abstract][Full Text] [Related]
2. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
Wu XQ; Huang C; He X; Tian YY; Zhou DX; He Y; Liu XH; Li J
Cell Signal; 2013 Dec; 25(12):2462-8. PubMed ID: 23993966
[TBL] [Abstract][Full Text] [Related]
3. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
4. Role of telomerase in the tumour microenvironment.
Liu N; Guo XH; Liu JP; Cong YS
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):357-364. PubMed ID: 31799699
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression.
Beck S; Jin X; Sohn YW; Kim JK; Kim SH; Yin J; Pian X; Kim SC; Nam DH; Choi YJ; Kim H
Mol Cells; 2011 Jan; 31(1):9-15. PubMed ID: 21193962
[TBL] [Abstract][Full Text] [Related]
6. TERT biology and function in cancer: beyond immortalisation.
Pestana A; Vinagre J; Sobrinho-Simões M; Soares P
J Mol Endocrinol; 2017 Feb; 58(2):R129-R146. PubMed ID: 28057768
[TBL] [Abstract][Full Text] [Related]
7. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
8. Telomerase: not just for the elongation of telomeres.
Calado RT; Chen J
Bioessays; 2006 Feb; 28(2):109-12. PubMed ID: 16435298
[TBL] [Abstract][Full Text] [Related]
9. Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies.
Li Y; Tergaonkar V
Cancer Res; 2014 Mar; 74(6):1639-44. PubMed ID: 24599132
[TBL] [Abstract][Full Text] [Related]
10. Telomerase regulation in hematological cancers: a matter of stemness?
Deville L; Hillion J; Ségal-Bendirdjian E
Biochim Biophys Acta; 2009 Apr; 1792(4):229-39. PubMed ID: 19419697
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Peifer M; Hertwig F; Roels F; Dreidax D; Gartlgruber M; Menon R; Krämer A; Roncaioli JL; Sand F; Heuckmann JM; Ikram F; Schmidt R; Ackermann S; Engesser A; Kahlert Y; Vogel W; Altmüller J; Nürnberg P; Thierry-Mieg J; Thierry-Mieg D; Mariappan A; Heynck S; Mariotti E; Henrich KO; Gloeckner C; Bosco G; Leuschner I; Schweiger MR; Savelyeva L; Watkins SC; Shao C; Bell E; Höfer T; Achter V; Lang U; Theissen J; Volland R; Saadati M; Eggert A; de Wilde B; Berthold F; Peng Z; Zhao C; Shi L; Ortmann M; Büttner R; Perner S; Hero B; Schramm A; Schulte JH; Herrmann C; O'Sullivan RJ; Westermann F; Thomas RK; Fischer M
Nature; 2015 Oct; 526(7575):700-4. PubMed ID: 26466568
[TBL] [Abstract][Full Text] [Related]
12. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.
Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A
J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314
[TBL] [Abstract][Full Text] [Related]
13. Cellular functions of the dual-targeted catalytic subunit of telomerase, telomerase reverse transcriptase--potential role in senescence and aging.
Ale-Agha N; Dyballa-Rukes N; Jakob S; Altschmied J; Haendeler J
Exp Gerontol; 2014 Aug; 56():189-93. PubMed ID: 24583100
[TBL] [Abstract][Full Text] [Related]
14. Telomerase and cancer stem cells.
Armanios M; Greider CW
Cold Spring Harb Symp Quant Biol; 2005; 70():205-8. PubMed ID: 16869755
[TBL] [Abstract][Full Text] [Related]
15. Telomeres and telomerase in cancer stem cells.
Ju Z; Rudolph KL
Eur J Cancer; 2006 Jun; 42(9):1197-203. PubMed ID: 16644207
[TBL] [Abstract][Full Text] [Related]
16. Telomere and telomerase as targets for cancer therapy.
Tian X; Chen B; Liu X
Appl Biochem Biotechnol; 2010 Mar; 160(5):1460-72. PubMed ID: 19412578
[TBL] [Abstract][Full Text] [Related]
17. CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis.
Kumar M; Witt B; Knippschild U; Koch S; Meena JK; Heinlein C; Weise JM; Krepulat F; Kuchenbauer F; Iben S; Rudolph KL; Deppert W; Günes C
Int J Cancer; 2013 May; 132(9):2032-43. PubMed ID: 23023397
[TBL] [Abstract][Full Text] [Related]
18. Telomerase: The Devil Inside.
Kumar M; Lechel A; Güneş Ç
Genes (Basel); 2016 Jul; 7(8):. PubMed ID: 27483324
[TBL] [Abstract][Full Text] [Related]
19. Blockade of telomerase reverse transcriptase enhances chemosensitivity in head and neck cancers through inhibition of AKT/ERK signaling pathways.
Zhao T; Hu F; Liu X; Tao Q
Oncotarget; 2015 Nov; 6(34):35908-21. PubMed ID: 26497550
[TBL] [Abstract][Full Text] [Related]
20. Telomerase targeted therapy in cancer and cancer stem cells.
Xu Y; He K; Goldkorn A
Clin Adv Hematol Oncol; 2011 Jun; 9(6):442-55. PubMed ID: 21841744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
